Literature DB >> 11283053

Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response.

C Figueiredo1, W Quint, N Nouhan, H van den Munckhof, P Herbrink, J Scherpenisse, W de Boer, P Schneeberger, G Perez-Perez, M J Blaser, L J van Doorn.   

Abstract

Helicobacter pylori strains can be distinguished by genotyping of virulence-associated genes, such as vacA and cagA. Because serological discrimination between strain types would reduce the need for endoscopy, 61 patients carrying H. pylori were studied by vacA and cagA genotyping of H. pylori in gastric biopsy specimens and by detection of specific serum antibodies. Serological responses to H. pylori were determined by Helicoblot (versions 2.0 and 2.1). Antibodies to CagA also were determined by a rapid anti-CagA assay (Pyloriset screen CagA) as well as by two noncommercially developed enzyme immunoassays, each using a recombinant CagA protein. Assessment of performance of the Helicoblot assays indicated substantial interobserver variation, with kappa values between 0.20 and 0.93. There was no relationship between the serological profiles on the Helicoblot and the genotypes from the same patients, except for strong associations between the presence of anti-CagA and the cagA-positive and vacA s1 H. pylori genotypes. Detection of anti-CagA by the five different assays varied considerably, with kappa values ranging from 0.21 to 0.78. Using the cagA genotype as the "gold standard," the sensitivity and specificity of the anti-CagA assays varied from 71.4 to 85.7% and from 54.2 to 100%, respectively. Thus, serological profiles of antibodies to H. pylori are heterogeneous and, with the exception of anti-CagA antibodies, show no relation to the H. pylori vacA and cagA genotypes. Detection of anti-CagA antibodies is strongly dependent on the test used.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283053      PMCID: PMC87936          DOI: 10.1128/JCM.39.4.1339-1344.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion.

Authors:  S Odenbreit; J Püls; B Sedlmaier; E Gerland; W Fischer; R Haas
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  CagA antibodies in Japanese children with nodular gastritis or peptic ulcer disease.

Authors:  S Kato; T Sugiyama; M Kudo; K Ohnuma; K Ozawa; K Iinuma; M Asaka; M J Blaser
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.

Authors:  S Maeda; H Yoshida; K Ogura; Y Yamaji; T Ikenoue; T Mitsushima; H Tagawa; R Kawaguchi; K Mori; K i Mafune; T Kawabe; Y Shiratori; M Omata
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

4.  Anti-CagA reactivity in Helicobacter pylori-negative subjects: a comparison of three different methods.

Authors:  M Fusconi; D Vaira; M Menegatti; S Farinelli; N Figura; J Holton; C Ricci; R Corinaldesi; M Miglioli
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

5.  Immunoblot analysis of humoral immune response to Helicobacter pylori in children with and without duodenal ulcer.

Authors:  G A Rocha; A M Oliveira; D M Queiroz; A S Carvalho; A M Nogueira
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: significance of anti-cagA antibodies.

Authors:  C Vaucher; B Janvier; J B Nousbaum; B Grignon; L Pezennec; M Robaszkiewicz; H Gouerou; B Picard; J L Fauchere
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 7.  Serological methods for diagnosis of Helicobacter pylori infection and monitoring of eradication therapy.

Authors:  P Herbrink; L J van Doorn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

8.  Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.

Authors:  S Kikuchi; J E Crabtree; D Forman; M Kurosawa
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

Review 9.  Production of a cytotoxin by Helicobacter pylori.

Authors:  R D Leunk
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

10.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

View more
  14 in total

1.  Heterogeneity of cag genotypes in Helicobacter pylori isolates from human biopsy specimens.

Authors:  Maria Luisa Tomasini; Stefania Zanussi; Michele Sozzi; Rosamaria Tedeschi; Giancarlo Basaglia; Paolo De Paoli
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 2.  Diagnosis of Helicobacter pylori: what should be the gold standard?

Authors:  Saurabh Kumar Patel; Chandra Bhan Pratap; Ashok Kumar Jain; Anil Kumar Gulati; Gopal Nath
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  New serological assay for detection of putative Helicobacter pylori virulence factors.

Authors:  Chang-Young Park; Yong-Kyun Cho; Tadashi Kodama; Hala M T El-Zimaity; Michael S Osato; David Y Graham; Yoshio Yamaoka
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2.

Authors:  Chandrabali Ghose; Guillermo I Perez-Perez; Victor J Torres; Marialuisa Crosatti; Abraham Nomura; Richard M Peek; Timothy L Cover; Fritz Francois; Martin J Blaser
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

5.  Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia?

Authors:  Francesco Franceschi; Nicoletta Di Simone; Silvia D'Ippolito; Roberta Castellani; Fiorella Di Nicuolo; Giovanni Gasbarrini; Yoshio Yamaoka; Tullia Todros; Giovanni Scambia; Antonio Gasbarrini
Journal:  Helicobacter       Date:  2012-06-29       Impact factor: 5.753

6.  Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.

Authors:  Lea Veijola; Aino Oksanen; Pentti Sipponen; Hilpi Rautelin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

7.  Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis.

Authors:  Noel Pabalan; Ofelia Francisco-Pabalan; Hamdi Jarjanazi; Hong Li; Lillian Sung; Hilmi Ozcelik
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

8.  Topographical localisation of cagA positive and cagA negative Helicobacter pylori strains in the gastric mucosa; an in situ hybridisation study.

Authors:  M Camorlinga-Ponce; C Romo; G González-Valencia; O Muñoz; J Torres
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

9.  Accuracy of a commercial enzyme-linked immunosorbent assay for CagA in patients from Brazil with and without gastric carcinoma.

Authors:  Andreia Maria Camargos Rocha; Gifone Aguiar Rocha; Adriana Santos; Celso Affonso de Oliveira; Dulciene Maria Magalhães Queiroz
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population.

Authors:  Quanbao Zhang; Yumin Li; Xun Li; Wence Zhou; Bin Shi; Hao Chen; Wenzhen Yuan
Journal:  Mol Biol Rep       Date:  2008-08-21       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.